Position in KROS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$531,832
+$276,180 QoQ
Shares Held
49,704
+114.6% QoQ
Ownership
0.251%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 131 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Derivatives in KROS
reported options exposure · as of Dec 31, 2025CallValue
$124,196
CallShares
6,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,205,173 across 455 Biotechnology names. KROS ranks #158 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in KROS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $531,832 | 49,704 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $255,652 | 23,157 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,521,421 | 74,726 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $124,196 | 6,100 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $1,567,762 | 99,100 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $1,617,085 | 121,130 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $609,972 | 59,860 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $1,702,389 | 107,542 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $3,485,012 | 60,014 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $1,142,134 | 24,992 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $4,611,227 | 69,656 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $10,328,057 | 259,760 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $1,578,410 | 49,511 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $1,542,630 | 38,393 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $1,253,074 | 29,346 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $1,821,638 | 37,935 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $3,670,771 | 97,575 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $937,126 | 33,917 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $691,712 | 12,720 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||